Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.

ABSTRACT:

Background

The multimorbid burden and use of systemic immunosuppressants in people with psoriasis may confer greater risk of adverse outcomes of coronavirus disease 2019 (COVID-19), but the data are limited.

Objective

Our aim was to characterize the course of COVID-19 in patients with psoriasis and identify factors associated with hospitalization.

Methods

Clinicians reported patients with psoriasis with confirmed/suspected COVID-19 via an international registry, Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection. Multiple logistic regression was used to assess the association between clinical and/or demographic characteristics and hospitalization. A separate patient-facing registry characterized risk-mitigating behaviors.

Result

SUBMITTER: Mahil SK 

PROVIDER: S-EPMC7566694 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature